The Technical AnalystExchange: XETRA Industry: Health Care Equipment & Services
Stratec SE Price, Forecast, Insider, Ratings, Fundamentals & Signals
-1.04% €42.85
Europe/Berlin / 2 mai 2024 @ 17:35
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 520.88 mill |
| EPS: | 1.070 |
| P/E: | 40.05 |
| Earnings Date: | Apr 26, 2024 |
| SharesOutstanding: | 12.16 mill |
| Avg Daily Volume: | 0.0091 mill |
| RATING 2024-05-02 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Neutral | |
| DE: | Strong Buy | |
| P/E: | Strong Buy | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 2.20x |
| Company: PE 40.05 | sector: PE 18.22 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.34x |
| Company: PE 40.05 | industry: PE 29.80 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
€26.95 (-37.10%) €-15.90 |
| Date: 2024-05-02 |
| Expected Trading Range (DAY) |
|---|
|
€ 41.46 - 44.34 ( +/- 3.35%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | €42.85 (-1.04% ) |
| Volume | 0.0044 mill |
| Avg. Vol. | 0.0091 mill |
| % of Avg. Vol | 48.10 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For SBS.DE
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
SBS.DE
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.